Increased food intake and CCK receptor antagonists: Beyond abdominal vagal afferents

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 286, Issue 6 55-6, 2004, Pages

  Ritter, Robert C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE;

BLOOD BRAIN BARRIER; DRUG MECHANISM; DRUG RECEPTOR BINDING; EDITORIAL; FOOD INTAKE; NEUROTRANSMISSION; PRIORITY JOURNAL; SATIETY; VAGOTOMY; VAGUS NERVE STIMULATION;

ANIMALS; DEVAZEPIDE; EATING; HORMONE ANTAGONISTS; NEURONS, AFFERENT; RATS; RECEPTORS, CHOLECYSTOKININ; VAGOTOMY; VAGUS NERVE;

EID: 2442699158     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00116.2004     Document Type: Editorial

References (44)

1. Blackshaw LA and Grundy D. Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibre. J Auton Nerv Syst 31: 191-201, 1990.
2. Blevins JE, Stanley BG, and Reidelberger RD. Brain regions where cholecystokinin suppresses feeding in rats. Brain Res 860: 1-10, 2000.
3. Brenner L and Ritter RC. Peptide cholecystokinin receptor antagonist increases food intake in rats. Appetite 24: 1-9, 1995.
4. Brenner L, Yox DP, and Ritter RC. Suppression of sham feeding by intraintestinal nutrients is not correlated with plasma cholecystokinin elevation. Am J Physiol Regul Integr Comp Physiol 264: R972-R976, 1993.
5. Broberger C, Holmberg K, Shi T, Dockray G, and Hokfelt T. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res 903: 128-140, 2001.
6. Corp ES, Curcio M, Gibbs J, and Smith GP. The effect of centrally administered CCK-receptor antagonists on food intake in rats. Physiol Behav 61: 823-827, 1997.
7. Corwin RL, Gibbs J, and Smith GP. Increased food intake after type A but not type B cholecystokinin receptor blockade. Physiol Behav 50: 255-258, 1991.
8. Davison JS and Clarke GD. Mechanical properties and sensitivity to CCK of vagal gastric slowly adapting mechanoreceptors. Am J Physiol Gastrointest Liver Physiol 255: G55-G61, 1988.
9. Della-Fera MA and Baile CA. CCK-octapeptide injected in CSF decreases meal size and daily food intake in sheep. Peptides 1: 51-54, 1980.
10. Della-Fera MA, Baile CA, Schneider BS, and Grinker JA. Cholecystokinin antibody injected in cerebral ventricles stimulates feeding in sheep. Science 212: 687-689, 1981.
11. Dorre D and Smith GP. CholecystokininB receptor antagonist increases food intake in rats. Physiol Behav 65: 11-14, 1998.
12. Gibbs J, Young RC, and Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495, 1973.
13. Gross PM, Wall KM, Pang JJ, Shaver SW, and Wainman DS. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 259: R1131-R1138, 1990.
14. Gross PM, Wall KM, Wainman DS, and Shaver SW. Subregional topography of capillaries in the dorsal vagal complex of rats. II. Physiological properties. J Comp Neurol 306: 83-94, 1991.
15. Harper AA and Raper HS. Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine. J Physiol 102: 115-125, 1943.
16. Hokfelt T, Cortes R, Schalling M, Ceccatelli S, Pelto-Huikko M, Persson H, and Villar MJ. Distribution patterns of CCK and CCK mRNA in some neuronal and non-neuronal tissues. Neuropeptides 19, Suppl: 31-43, 1991.
17. Honda T, Wada E, Battey JF, and Wank SA. Differential gene expression of CCK-A and CCK-B receptors in the rat brain. Mol Cell Neurosci 4: 143-154, 1993.
18. Ivy AC and Oldberg EA. A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol 86: 599-613, 1928.
19. Milligan G. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol 64: 1271-1276, 2003.
20. Moran TH, Ameglio PJ, Peyton HJ, Schwartz GJ, and McHugh PR. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 265: R620-R624, 1993.
21. Moran TH, Smith GP, Hostetler AM, and McHugh PR. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res 415: 149-152, 1987.
22. Mutt V and Jorpes JE. Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem 6: 156-162, 1968.
23. Oldendorf WH. Blood-brain barrier permeability to peptides: pitfalls in measurement. Peptides 2, Suppl 2: 109-111, 1981.
24. Phillips RJ, Baronowsky EA, and Powley TL. Long-term regeneration of abdominal vagus: efferents fail while afferents succeed. J Comp Neurol 455: 222-237, 2003.
25. Pullen RG and Hodgson OJ. Penetration of diazepam and the nonpeptide CCK antagonist, L-364,718, into rat brain. J Pharm Pharmacol 39: 863-864, 1987.
26. Reidelberger RD. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats. Am J Physiol Regul Integr Comp Physiol 263: R1354-R1358, 1992.
27. Reidelberger RD and O'Rourke MF. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats. Am J Physiol Regul Integr Comp Physiol 257: R1512-R1518, 1989.
28. Reidelberger RD, Hernandez J, Fritzsch B, and Hulce M. Abdominal vagal mediation of the satiety effects of CCK in rats. Am J Physiol Regul Integr Comp Physiol 286: R1005-R1012, 2004.
29. Ritter RC, Brenner LA, and Tamura CS. Endogenous CCK and the peripheral neural substrates of intestinal satiety. Ann NY Acad Sci 713: 255-267, 1994.
30. Ritter RC, Covasa M, and Matson CA. Cholecystokinin: proofs and prospects for involvement in control of food intake and body weight. Neuropeptides 33: 387-399, 1999.
31. Ritter RC and Ladenheim, EE. Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin. Am J Physiol Regul Integr Comp Physiol 248: R501-R504, 1985.
32. Ritter RC and Malbasa Z. CCK-A receptor antagonist increases food intake in capsaicin-treated rats. Soc Neurosci Abstr 21: 460, 1995.
33. Ritter S, Bugarith K, and Dinh TT. Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J Comp Neurol 432: 197-216, 2001.
34. Ritter S, Watts AG, Dinh TT, Sanchez-Watts G, and Pedrow C. Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion. Endocrinology 144: 1357-1367, 2003.
35. Scheurink A and Ritter S. Sympathoadrenal responses to glucoprivation and lipoprivation in rats. Physiol Behav 53: 995-1000, 1993.
36. Schick RR, Reilly WM, Roddy DR, Yaksh TL, and Go VL. Neuronal cholecystokinin-like immunoreactivity is postprandially released from primate hypothalamus. Brain Res 418: 20-26, 1987.
37. Schick RR, Yaksh TL, and Go VL. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats-pharmacological characterization of this action. Regul Pept 14: 277-291, 1986,
38. Schick RR, Yaksh TL, and Go VL. An intragastric meal releases the putative satiety factor cholecystokinin from hypothalamic neurons in cats. Brain Res 370: 349-353, 1986.
39. Schick RR, Yaksh TL, Roddy DR, and Go VL. Release of hypothalamic cholecystokinin in cats: effects of nutrient and volume loading. Am J Physiol Regul Integr Comp Physiol 256: R248-R254, 1989.
40. Simasko SM, Wiens J, Karpiel A, Covasa M, and Ritter RC. Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons. Am J Physiol Regul Integr Comp Physiol 283: R1303-R1313, 2002.
41. Smith GP, Jerome C, and Norgren R. Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats. Am J Physiol Regul Integr Comp Physiol 249: R638-R641, 1985.
42. Woltman TA, Hulce M, and Reidelberger RD. Relative blood-brain barrier permeabilities of the cholecystokinin receptor antagonists devazepide and A-65186 in rats. J Pharm Pharmacol 51: 917-920, 1999.
43. Yox DP, Brenner L, and Ritter RC. CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients. Am J Physiol Regul Integr Comp Physiol 262: R554-R561, 1992.
44. Yox DP and Ritter RC. Capsaicin attenuates suppression of sham feeding induced by intestinal nutrients. Am J Physiol Regul Integr Comp Physiol 255: R569-R574, 1988.